Dimension Therapeutics, Inc. Proceeds from Issuance Initial Public Offering
Dimension Therapeutics, Inc. reported Proceeds from Issuance Initial Public Offering of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2017-03-09
- Dimension Therapeutics, Inc. proceeds from issuance initial public offering for the quarter ending 2016-09-30 was $0.00.
- Dimension Therapeutics, Inc. proceeds from issuance initial public offering for the quarter ending 2016-06-30 was $0.00.
- Dimension Therapeutics, Inc. proceeds from issuance initial public offering for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- Dimension Therapeutics, Inc. proceeds from issuance initial public offering for fiscal 2015 was $67.76M.
- Dimension Therapeutics, Inc. proceeds from issuance initial public offering for fiscal 2014 was $0.00.
| Period end | Proceeds from Issuance Initial Public Offering 3 month | Proceeds from Issuance Initial Public Offering 6 month | Proceeds from Issuance Initial Public Offering 12 month | Proceeds from Issuance Initial Public Offering 33 month | Proceeds from Issuance Initial Public Offering 36 month | Proceeds from Issuance Initial Public Offering 39 month |
|---|---|---|---|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-09 | |||||
| 2016-09-30 | $0.00 derived: 10-Q 39 month − 10-Q 36 month · filed 2016-11-10 | $0.00 derived: sum of 2 quarters · filed 2016-11-10 | $64.62M 10-Q · filed 2016-11-10 | |||
| 2016-06-30 | $0.00 derived: 10-Q 36 month − 10-Q 33 month · filed 2016-08-11 | $64.62M 10-Q · filed 2016-08-11 | ||||
| 2016-03-31 | $64.62M 10-Q · filed 2016-05-12 | |||||
| 2015-12-31 | $67.76M 10-K · filed 2017-03-09 | |||||
| 2014-12-31 | $0.00 10-K · filed 2017-03-09 |